{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:30:59Z","timestamp":1760239859174,"version":"build-2065373602"},"reference-count":133,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"am","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.hoc.2022.07.008","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T22:17:33Z","timestamp":1666045053000},"page":"943-960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Germline Testing for Individuals with Pancreatic Adenocarcinoma and Novel Genetic Risk Factors"],"prefix":"10.1016","volume":"36","author":[{"given":"Anu","family":"Chittenden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigurdis","family":"Haraldsdottir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Nissim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.hoc.2022.07.008_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Electronic address aadhe, Cancer Genome Atlas Research N. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma","volume":"32","year":"2017","journal-title":"Cancer cell"},{"issue":"3","key":"10.1016\/j.hoc.2022.07.008_bib2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2014.11.042","article-title":"Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer","volume":"148","author":"Grant","year":"2015","journal-title":"Gastroenterology"},{"issue":"28","key":"10.1016\/j.hoc.2022.07.008_bib3","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1200\/JCO.2014.59.7401","article-title":"Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma","volume":"33","author":"Holter","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1158\/1055-9965.EPI-15-0455","article-title":"Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients","volume":"25","author":"Hu","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"30","key":"10.1016\/j.hoc.2022.07.008_bib5","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1200\/JCO.2017.72.3502","article-title":"Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma","volume":"35","author":"Shindo","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"24","key":"10.1016\/j.hoc.2022.07.008_bib6","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1002\/cncr.29664","article-title":"Identification of germline genetic mutations in patients with pancreatic cancer","volume":"121","author":"Salo-Mullen","year":"2015","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.008_bib7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.7326\/0003-4819-97-2-282_1","article-title":"Pancreatic carcinoma in brothers","volume":"97","author":"Dat","year":"1982","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.hoc.2022.07.008_bib8","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/1097-0142(19870501)59:9<1661::AID-CNCR2820590923>3.0.CO;2-H","article-title":"Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature","volume":"59","author":"Ehrenthal","year":"1987","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.hoc.2022.07.008_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1399-0004.1976.tb01598.x","article-title":"Familial carcinoma of the pancreas","volume":"9","author":"Friedman","year":"1976","journal-title":"Clin Genet"},{"issue":"5\u20136","key":"10.1016\/j.hoc.2022.07.008_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF02788437","article-title":"Cancer of the pancreas in two brothers and one sister","volume":"2","author":"Ghadirian","year":"1987","journal-title":"Int J Pancreatol"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0016-5085(19)33156-7","article-title":"Adenocarcinoma of the pancreas in four siblings","volume":"65","author":"MacDermott","year":"1973","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.008_bib12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.hoc.2015.04.007","article-title":"Familial Pancreatic Adenocarcinoma","volume":"29","author":"Petersen","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"issue":"7","key":"10.1016\/j.hoc.2022.07.008_bib13","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1158\/0008-5472.CAN-03-3823","article-title":"Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds","volume":"64","author":"Klein","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.hoc.2022.07.008_bib14","article-title":"Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer","author":"Roberts","year":"2015","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/gim.2017.85","article-title":"Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history","volume":"20","author":"Chaffee","year":"2018","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41436-018-0009-5","article-title":"Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer","volume":"21","author":"Yurgelun","year":"2019","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","article-title":"Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium","volume":"69","author":"Goggins","year":"2020","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.008_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1200\/JCO.18.01489","article-title":"Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion","volume":"37","author":"Stoffel","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.hoc.2022.07.008_bib20","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","author":"Breast Cancer Linkage","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"13","key":"10.1016\/j.hoc.2022.07.008_bib21","first-page":"3789","article-title":"Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17","volume":"62","author":"Murphy","year":"2002","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.hoc.2022.07.008_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jnci\/95.3.214","article-title":"BRCA2 germline mutations in familial pancreatic carcinoma","volume":"95","author":"Hahn","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.hoc.2022.07.008_bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/gim.2014.153","article-title":"BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study","volume":"17","author":"Zhen","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.008_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1055-9965.EPI-06-0783","article-title":"The prevalence of BRCA2 mutations in familial pancreatic cancer","volume":"16","author":"Couch","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"17","key":"10.1016\/j.hoc.2022.07.008_bib25","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1002\/cncr.31628","article-title":"Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma","volume":"124","author":"Brand","year":"2018","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.hoc.2022.07.008_bib26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jnci\/djy024","article-title":"Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms","volume":"110","author":"Lowery","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.hoc.2022.07.008_bib27","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group","volume":"83","year":"2000","journal-title":"Br J Cancer"},{"issue":"9016","key":"10.1016\/j.hoc.2022.07.008_bib28","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0140-6736(96)91484-1","article-title":"Germline BRCA1 185delAG mutations in Jewish women with breast cancer","volume":"347","author":"Offit","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.008_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.GIM.0000159902.34833.26","article-title":"What's the message? Interpretation of an uninformative BRCA1\/2 test result for women at risk of familial breast cancer","volume":"7","author":"van Dijk","year":"2005","journal-title":"Genet Med"},{"issue":"18","key":"10.1016\/j.hoc.2022.07.008_bib30","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":"Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program","volume":"94","author":"Brose","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"18","key":"10.1016\/j.hoc.2022.07.008_bib31","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer Incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.hoc.2022.07.008_bib32","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/j.gastro.2009.06.055","article-title":"Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer","volume":"137","author":"Tischkowitz","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.hoc.2022.07.008_bib33","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1399-0004.2010.01425.x","article-title":"PALB2 mutations in European familial pancreatic cancer families","volume":"78","author":"Slater","year":"2010","journal-title":"Clin Genet"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.008_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10689-011-9426-1","article-title":"PALB2 mutations in familial breast and pancreatic cancer","volume":"10","author":"Hofstatter","year":"2011","journal-title":"Fam Cancer"},{"issue":"7","key":"10.1016\/j.hoc.2022.07.008_bib35","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.19.01907","article-title":"Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families","volume":"38","author":"Yang","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.008_bib36","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","article-title":"A\u00a020-year perspective on the International Fanconi Anemia Registry (IFAR)","volume":"101","author":"Kutler","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/2159-8290.CD-11-0194","article-title":"ATM mutations in patients with hereditary pancreatic cancer","volume":"2","author":"Roberts","year":"2012","journal-title":"Cancer Discov"},{"issue":"5","key":"10.1016\/j.hoc.2022.07.008_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/gepi.21971","article-title":"Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk","volume":"40","author":"Marabelli","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"8","key":"10.1016\/j.hoc.2022.07.008_bib39","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/ng.3342","article-title":"Loss-of-function variants in ATM confer risk of gastric cancer","volume":"47","author":"Helgason","year":"2015","journal-title":"Nat Genet"},{"issue":"23","key":"10.1016\/j.hoc.2022.07.008_bib40","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1001\/jama.2018.6228","article-title":"Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer","volume":"319","author":"Hu","year":"2018","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.008_bib41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1158\/1940-6207.CAPR-20-0448","article-title":"Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (ATM) Gene are Associated with High and Moderate Risks for Multiple Cancers","volume":"14","author":"Hall","year":"2021","journal-title":"Cancer Prev Res (Phila)"},{"issue":"11","key":"10.1016\/j.hoc.2022.07.008_bib42","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jamaoncol.2021.3701","article-title":"Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene","volume":"7","author":"Hsu","year":"2021","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.228452.113","article-title":"Familial pancreatic cancer: genetic advances","volume":"28","author":"Rustgi","year":"2014","journal-title":"Genes Dev"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.008_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc.2015.21","article-title":"BRCAness revisited","volume":"16","author":"Lord","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.008_bib45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA Damage Response in Cancer","volume":"60","author":"O'Connor","year":"2015","journal-title":"Mol Cell"},{"issue":"15","key":"10.1016\/j.hoc.2022.07.008_bib46","first-page":"1492","article-title":"Maintenance Olaparib for Metastatic Pancreatic Cancer. Reply","volume":"381","author":"Golan","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","article-title":"Germline p16 mutations in familial melanoma","volume":"8","author":"Hussussian","year":"1994","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.008_bib48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","article-title":"Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents","volume":"44","author":"Goldstein","year":"2007","journal-title":"J\u00a0Med Genet"},{"issue":"15","key":"10.1016\/j.hoc.2022.07.008_bib49","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM199510123331505","article-title":"Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene","volume":"333","author":"Whelan","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib50","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cncr.10159","article-title":"Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome","volume":"94","author":"Lynch","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2022.07.008_bib51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13053-018-0088-y","article-title":"CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome","volume":"16","author":"Cremin","year":"2018","journal-title":"Hered Cancer Clin Pract"},{"issue":"10","key":"10.1016\/j.hoc.2022.07.008_bib52","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/jnci\/djh136","article-title":"Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families","volume":"96","author":"Chaudru","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.hoc.2022.07.008_bib53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/jmedgenet-2014-102320","article-title":"High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families","volume":"51","author":"Helgadottir","year":"2014","journal-title":"J\u00a0Med Genet"},{"issue":"9","key":"10.1016\/j.hoc.2022.07.008_bib54","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1212\/WNL.43.9.1728","article-title":"A\u00a0familial syndrome with cutaneous malignant melanoma and cerebral astrocytoma","volume":"43","author":"Kaufman","year":"1993","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.hoc.2022.07.008_bib55","first-page":"2298","article-title":"Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors","volume":"58","author":"Bahuau","year":"1998","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.hoc.2022.07.008_bib56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2015.08.038","article-title":"Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome","volume":"74","author":"Soura","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"20","key":"10.1016\/j.hoc.2022.07.008_bib57","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","article-title":"High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL","volume":"66","author":"Goldstein","year":"2006","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.hoc.2022.07.008_bib58","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ijc.27316","article-title":"Cellular senescence and tumor suppressor gene p16","volume":"130","author":"Rayess","year":"2012","journal-title":"Int J Cancer"},{"issue":"23","key":"10.1016\/j.hoc.2022.07.008_bib59","first-page":"6078","article-title":"Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb","volume":"54","author":"Li","year":"1994","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF03401664","article-title":"The CDKN2A (p16) gene and human cancer","volume":"3","author":"Foulkes","year":"1997","journal-title":"Mol Med"},{"issue":"17","key":"10.1016\/j.hoc.2022.07.008_bib61","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","article-title":"The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2","volume":"17","author":"Stott","year":"1998","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib62","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13053-021-00178-x","article-title":"CDKN2A germline alterations and the relevance of genotype-phenotype associations in cancer predisposition","volume":"19","author":"Chan","year":"2021","journal-title":"Hered Cancer Clin Pract"},{"issue":"11","key":"10.1016\/j.hoc.2022.07.008_bib63","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1158\/1055-9965.EPI-17-1065","article-title":"CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations","volume":"27","author":"McWilliams","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.008_bib64","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1017\/thg.2015.12","article-title":"Prevalence of Germline BAP1, CDKN2A, and CDK4 Mutations in an Australian Population-Based Sample of Cutaneous Melanoma Cases","volume":"18","author":"Aoude","year":"2015","journal-title":"Twin Res Hum Genet"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib65","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1897-4287-12-20","article-title":"Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom","volume":"12","author":"Harland","year":"2014","journal-title":"Hered Cancer Clin Pract"},{"issue":"8","key":"10.1016\/j.hoc.2022.07.008_bib66","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/MPA.0000000000001888","article-title":"The Role of Inherited Pathogenic CDKN2A Variants in Susceptibility to Pancreatic Cancer","volume":"50","author":"Kimura","year":"2021","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.hoc.2022.07.008_bib67","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/gcc.20410","article-title":"The M53I mutation in CDKN2A is a founder mutation that predominates in melanoma patients with Scottish ancestry","volume":"46","author":"Lang","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.008_bib68","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/CMR.0b013e3282f1d328","article-title":"The p.G23S CDKN2A founder mutation in high-risk melanoma families from Central Italy","volume":"17","author":"Gensini","year":"2007","journal-title":"Melanoma Res"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.008_bib69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1054\/bjoc.2001.1944","article-title":"A\u00a0common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families","volume":"85","author":"Goldstein","year":"2001","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.008_bib70","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/gcc.1124","article-title":"Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families","volume":"31","author":"Hashemi","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.008_bib71","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/1097-0215(20000915)87:6<809::AID-IJC8>3.0.CO;2-U","article-title":"Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden)","volume":"87","author":"Vasen","year":"2000","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.008_bib72","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/303001","article-title":"A\u00a0single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families","volume":"67","author":"Ciotti","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.hoc.2022.07.008_bib73","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/jmg.2007.055376","article-title":"CDKN2A mutations and melanoma risk in the Icelandic population","volume":"45","author":"Goldstein","year":"2008","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.hoc.2022.07.008_bib74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2350-15-59","article-title":"A\u00a0large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma","volume":"15","author":"Frigerio","year":"2014","journal-title":"BMC Med Genet"},{"issue":"7","key":"10.1016\/j.hoc.2022.07.008_bib75","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/gut.2009.198499","article-title":"Peutz-Jeghers syndrome: a systematic review and recommendations for management","volume":"59","author":"Beggs","year":"2010","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.008_bib76","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ajg.2009.725","article-title":"High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations","volume":"105","author":"van Lier","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.008_bib77","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1053\/gast.2000.20228","article-title":"Very high risk of cancer in familial Peutz-Jeghers syndrome","volume":"119","author":"Giardiello","year":"2000","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.hoc.2022.07.008_bib78","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1158\/1078-0432.CCR-06-0083","article-title":"Frequency and spectrum of cancers in the Peutz-Jeghers syndrome","volume":"12","author":"Hearle","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.008_bib79","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/bjc.2015.261","article-title":"Targeting LKB1 in cancer - exposing and exploiting vulnerabilities","volume":"113","author":"Momcilovic","year":"2015","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.hoc.2022.07.008_bib80","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10689-017-0037-3","article-title":"An exploration of genotype-phenotype link between Peutz-Jeghers syndrome and STK11: a review","volume":"17","author":"Daniell","year":"2018","journal-title":"Fam Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.008_bib81","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/humu.20253","article-title":"High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome","volume":"26","author":"Aretz","year":"2005","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.008_bib82","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MPG.0000000000002166","article-title":"Clinical and Genetic Study of Children With Peutz-Jeghers Syndrome Identifies a High Frequency of STK11 De Novo Mutation","volume":"68","author":"Zhao","year":"2019","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib83","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10689-018-0093-3","article-title":"Low-level parental mosaicism in an apparent de novo case of Peutz-Jeghers syndrome","volume":"18","author":"Butel-Simoes","year":"2019","journal-title":"Fam Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.008_bib84","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","article-title":"Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?","volume":"71","author":"Li","year":"1969","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib85","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jmg.38.1.43","article-title":"Sensitivity and predictive value of criteria for p53 germline mutation screening","volume":"38","author":"Chompret","year":"2001","journal-title":"J\u00a0Med Genet"},{"issue":"26","key":"10.1016\/j.hoc.2022.07.008_bib86","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1200\/JCO.2009.22.7967","article-title":"2009 version of the Chompret criteria for Li Fraumeni syndrome","volume":"27","author":"Tinat","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"34","key":"10.1016\/j.hoc.2022.07.008_bib87","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1038\/sj.onc.1204621","article-title":"Relative frequency and morphology of cancers in carriers of germline TP53 mutations","volume":"20","author":"Birch","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.hoc.2022.07.008_bib88","first-page":"101","article-title":"Germline mutations in the TP53 gene","volume":"25","author":"Eeles","year":"1995","journal-title":"Cancer Surv"},{"issue":"10","key":"10.1016\/j.hoc.2022.07.008_bib89","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41431-020-0638-4","article-title":"European Reference Network G. Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes","volume":"28","author":"Frebourg","year":"2020","journal-title":"Eur J Hum Genet"},{"issue":"23","key":"10.1016\/j.hoc.2022.07.008_bib90","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"issue":"4985","key":"10.1016\/j.hoc.2022.07.008_bib91","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"issue":"6303","key":"10.1016\/j.hoc.2022.07.008_bib92","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/348747a0","article-title":"Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome","volume":"348","author":"Srivastava","year":"1990","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.008_bib93","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","article-title":"Putting p53 in Context","volume":"170","author":"Kastenhuber","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.hoc.2022.07.008_bib94","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s12094-019-02236-2","article-title":"Li-Fraumeni syndrome heterogeneity","volume":"22","author":"Gargallo","year":"2020","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.008_bib95","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026187","article-title":"Inherited TP53 Mutations and the Li-Fraumeni Syndrome","volume":"7","author":"Guha","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"10.1016\/j.hoc.2022.07.008_bib96","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1001\/jamaoncol.2021.4398","article-title":"Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis","volume":"7","author":"Kratz","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.hoc.2022.07.008_bib97","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jsbmb.2019.04.011","article-title":"Clinical spectrum of Li-Fraumeni syndrome\/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation","volume":"190","author":"Ferreira","year":"2019","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib98","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/humu.23673","article-title":"Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis","volume":"40","author":"de Andrade","year":"2019","journal-title":"Hum Mutat"},{"issue":"21","key":"10.1016\/j.hoc.2022.07.008_bib99","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers","volume":"33","author":"Bougeard","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2022.07.008_bib100","article-title":"UKCGG Consensus Group guidelines for the management of patients with constitutional TP53 pathogenic variants","author":"Hanson","year":"2020","journal-title":"J\u00a0Med Genet"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib101","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13058-019-1193-1","article-title":"Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis","volume":"21","author":"Batalini","year":"2019","journal-title":"Breast Cancer Res"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.008_bib102","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/humu.22552","article-title":"TP53 mutations in human cancer: database reassessment and prospects for the next decade","volume":"35","author":"Leroy","year":"2014","journal-title":"Hum Mutat"},{"issue":"10","key":"10.1016\/j.hoc.2022.07.008_bib103","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jmg.2008.058958","article-title":"High frequency of de novo mutations in Li-Fraumeni syndrome","volume":"46","author":"Gonzalez","year":"2009","journal-title":"J\u00a0Med Genet"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.008_bib104","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/jmg.2009.073429","article-title":"TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes","volume":"47","author":"Ruijs","year":"2010","journal-title":"J\u00a0Med Genet"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/CCO.0000000000000423","article-title":"Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome","volume":"30","author":"Amadou","year":"2018","journal-title":"Curr Opin Oncol"},{"issue":"7407","key":"10.1016\/j.hoc.2022.07.008_bib108","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Cancer Genome Atlas","year":"2012","journal-title":"Nature"},{"issue":"6349","key":"10.1016\/j.hoc.2022.07.008_bib109","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/genes12010033","article-title":"Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer","volume":"12","author":"Ghidini","year":"2020","journal-title":"Genes (Basel)"},{"issue":"16","key":"10.1016\/j.hoc.2022.07.008_bib111","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1001\/jama.2009.1529","article-title":"Risk of pancreatic cancer in families with Lynch syndrome","volume":"302","author":"Kastrinos","year":"2009","journal-title":"Jama"},{"issue":"9","key":"10.1016\/j.hoc.2022.07.008_bib112","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1200\/JCO.2011.39.5590","article-title":"Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study","volume":"30","author":"Win","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.008_bib113","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1053\/j.gastro.2013.01.069","article-title":"Genetic risk factors for pancreatic disorders","volume":"144","author":"Whitcomb","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib114","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ng.2007.44","article-title":"Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis","volume":"40","author":"Rosendahl","year":"2008","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.hoc.2022.07.008_bib115","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ng.2730","article-title":"Variants in CPA1 are strongly associated with early onset chronic pancreatitis","volume":"45","author":"Witt","year":"2013","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.008_bib116","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jnci\/89.6.442","article-title":"Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group","volume":"89","author":"Lowenfels","year":"1997","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib117","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1572-0241.2007.01597.x","article-title":"Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series","volume":"103","author":"Rebours","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"18","key":"10.1016\/j.hoc.2022.07.008_bib118","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1073\/pnas.1720588115","article-title":"Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer","volume":"115","author":"Tamura","year":"2018","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.008_bib119","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.giec.2018.06.001","article-title":"The Role of Genetics in Pancreatitis","volume":"28","author":"Hasan","year":"2018","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.008_bib120","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.soc.2021.06.002","article-title":"Inherited Pancreatic Cancer Syndromes and High-Risk Screening","volume":"30","author":"Biller","year":"2021","journal-title":"Surg Oncol Clin N Am"},{"issue":"14","key":"10.1016\/j.hoc.2022.07.008_bib121","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/cncr.32077","article-title":"Family communication and patient distress after germline genetic testing in individuals with pancreatic ductal adenocarcinoma","volume":"125","author":"Peters","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2022.07.008_bib122","article-title":"Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing","author":"Wang","year":"2021","journal-title":"J\u00a0Med Genet"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib123","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13053-015-0034-1","article-title":"Patient experiences living with pancreatic cancer risk","volume":"13","author":"Underhill","year":"2015","journal-title":"Hered Cancer Clin Pract"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.008_bib124","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.dld.2020.11.024","article-title":"Low-frequency of RABL3 pathogenetic variants in hereditary and familial pancreatic cancer","volume":"53","author":"Puzzono","year":"2021","journal-title":"Dig Liver Dis"},{"issue":"8","key":"10.1016\/j.hoc.2022.07.008_bib125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/gcc.22947","article-title":"Familial Pancreatic Cancer Genome Sequencing P. Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants","volume":"60","author":"Roberts","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"10.1016\/j.hoc.2022.07.008_bib126","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/s41588-019-0475-y","article-title":"Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer","volume":"51","author":"Nissim","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2022.07.008_bib127","unstructured":"2021. Available at: http:\/\/gepia.cancer-pku.cn\/detail.php?gene=RABL3. Accessed December 20, 2021."},{"key":"10.1016\/j.hoc.2022.07.008_bib128","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.humpath.2017.07.008","article-title":"Overexpression of Rabl3 and Cullin7 is associated with pathogenesis and poor prognosis in hepatocellular carcinoma","volume":"67","author":"An","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.hoc.2022.07.008_bib129","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.12659\/MSM.898632","article-title":"High Expression of Rab-like 3 (Rabl3) is Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer via Repression of MAPK8\/9\/10-Mediated Autophagy","volume":"22","author":"Zhang","year":"2016","journal-title":"Med Sci Monit"},{"issue":"49","key":"10.1016\/j.hoc.2022.07.008_bib130","doi-asserted-by":"crossref","first-page":"E5272","DOI":"10.1073\/pnas.1419064111","article-title":"Measuring missing heritability: inferring the contribution of common variants","volume":"111","author":"Golan","year":"2014","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.008_bib131","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrg3118","article-title":"Rare and common variants: twenty arguments","volume":"13","author":"Gibson","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"9","key":"10.1016\/j.hoc.2022.07.008_bib132","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.hoc.2022.07.008_bib133","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ng.429","article-title":"Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer","volume":"41","author":"Amundadottir","year":"2009","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.hoc.2022.07.008_bib134","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ng.522","article-title":"A\u00a0genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33","volume":"42","author":"Petersen","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2022.07.008_bib135","doi-asserted-by":"crossref","unstructured":"Wolpin BM, Rizzato C, Kraft P, et\u00a0al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet 2014;46(9):994-1000.","DOI":"10.1038\/ng.3052"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.008_bib136","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/gutjnl-2012-303477","article-title":"Genome-wide association study of survival in patients with pancreatic adenocarcinoma","volume":"63","author":"Wu","year":"2014","journal-title":"Gut"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858822000764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858822000764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:20:13Z","timestamp":1760185213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858822000764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":133,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0889858822000764"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2022.07.008","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline Testing for Individuals with Pancreatic Adenocarcinoma and Novel Genetic Risk Factors","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2022.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}